Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | HROW | Common Stock | Options Exercise | +88K | +6.14% | 1.52M | Jan 2, 2023 | Direct | F1 | ||
transaction | HROW | Common Stock | Tax liability | -$519K | -35.2K | -2.31% | $14.76 | 1.48M | Jan 2, 2023 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | HROW | Restricted Stock Unit | Options Exercise | $0 | -88K | -100% | $0.00* | 0 | Jan 2, 2023 | Common Stock | 88K | $0.00 | Direct | F1 |
Id | Content |
---|---|
F1 | The listed Acquired (as described in the table above) 88,000 shares of Harrow Health, Inc. ("Harrow") common stock represent restricted stock units ("RSUs") granted to Mr. Baum under the Issuer's 2017 Stock Incentive and Awards Plan on January 2, 2020. The RSUs, which vested in full on January 2, 2023, the third-year anniversary of the grant of the same, settled as one share of common stock for each RSU. The listed Disposed (as described in the table above) 35,179 shares of Harrow common stock were not sold by Mr. Baum in any transaction; rather, they were shares of Harrow common stock withheld, by the Company, from the same aforementioned 88,000 RSU share issuance for payroll tax purposes only. |